Program Chair

Steven I. Sherman, MD
The University of Texas MD Anderson Cancer Center
Houston, TX

Faculty

Bryan R. Haugen, MD
University of CO Denver
Aurora, CO

Maria Cabanillas, MD
The University of Texas MD Anderson Cancer Center
Houston, TX

DISCLOSURE POLICY

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The following faculty reported no relevant financial relationships during the content development process for this activity: Bryan R. Haugen, MD

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:
Steven I. Sherman, MD:Consulting, Ignyta, Eisai, Bristol-Myers Squibb, Genzyme
Maria Cabanillas:Advisory Board Member, Ignyta, LOXO, Blueprint; Research Investigator, Genentech, Inc., Eisai, Exelixis, Inc., Kura

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:  
Giuseppe Barbesino, MD: Advisory Boards, Horizon Pharmaceuticals, Ipsen Pharmaceuticals; Spouse, employee of Genzyme
 

The following SPC members reported relevant financial relationships:
Andrew Ahmann, MD:Research Support, Dexcom, Medtronic; Consultant, Dexcom, Eli Lilly & Company, Horizon CME, MannKind, Novo Nordisk, Sanofi; Speaker, Horizon CME; Principle Investigator, National Institute of Health, T1D Exchange, Trial Net
Joan Han, MD: Research Support, Rhythm Pharmaceuticals; Principle Investigator, Insys Therapeutics, Rhythm Pharmaceuticals
Steven T. Harris, MD:Ad hoc consultant on Advisory Boards, Eli Lilly & Company, Radius Health; Speaker, Amgen, Eli Lilly & Company, Radius Health
Jonathan Purnell, MD: Advisor, Novo Nordisk
Neda Rasouli, MD:Research Support, Novo Nordisk, Boehringer Ingelheim, Rhythm Pharmaceuticals, Elira Therapeutics; Consultant, Intarcia
Amy Rothberg, MD:Spouse, consultant of Merck
Susmeeta Sharma, MD: Speaker, Corcept

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Beret Ann Casey, MD, Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Deborah Sellmeyer, MD

Endocrine Society staff associated with the development of content for this activity reported no relevant financial relationships.